Aimei Health Technology Co., Ltd Ordinary Share (AFJK) is a publicly traded Financial Services sector company. As of July 9, 2026, AFJK trades at $20.10 with a market cap of $84.51M and a P/E ratio of 0.00. AFJK moved +0.00% today. Year to date, AFJK is +2.61%; over the trailing twelve months it is +151.08%. Its 52-week range spans $6.75 to $130.37. Rallies surfaces AFJK's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Aimei Health Terminates Business Combination with United Hydrogen After July 7, 2026 Deadline: Aimei Health Technology terminated its June 19, 2024 business combination agreement with United Hydrogen Group on July 7, 2026 after the extended outside date expired, as amended June 6, 2025. The deal’s collapse frees Aimei from merger obligations and redirects management to pursue new strategic transactions.
| Metric | Value |
|---|---|
| Price | $20.10 |
| Market Cap | $84.51M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $130.37 |
| 52-Week Low | $6.75 |
| Volume | 312 |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $1.06M |
| Gross Margin | 0.00% |
AFJK analyst coverage data. Average price target: $0.00.